|
ARSK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.023160E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.004980E-03 |
| Normal-vs-Stage2 |
3.419900E-03 |
| Normal-vs-Stage3 |
6.361700E-02 |
| Normal-vs-Stage4 |
9.934800E-01 |
| Stage1-vs-Stage2 |
7.168400E-01 |
| Stage1-vs-Stage3 |
6.218200E-01 |
| Stage1-vs-Stage4 |
1.697970E-01 |
| Stage2-vs-Stage3 |
4.622600E-01 |
| Stage2-vs-Stage4 |
2.305400E-01 |
| Stage3-vs-Stage4 |
3.098000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.186900E-04 |
| Normal-vs-AfricanAmerican |
7.401600E-02 |
| Normal-vs-Asian |
9.632400E-01 |
| Caucasian-vs-AfricanAmerican |
5.100400E-01 |
| Caucasian-vs-Asian |
3.064200E-01 |
| AfricanAmerican-vs-Asian |
5.577400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.38200000000077E-05 |
| Normal-vs-Female |
7.319800E-01 |
| Male-vs-Female |
1.131990E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.532020E-02 |
| Normal-vs-Extreme_Weight |
4.847400E-04 |
| Normal-vs-Obese |
7.691700E-02 |
| Normal-vs-Extreme_Obese |
1.211870E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.956600E-01 |
| Normal_Weight-vs-Obese |
5.695600E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.028200E-01 |
| Extreme_Weight-vs-Obese |
2.863000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.442000E-01 |
| Obese-vs-Extreme_Obese |
5.116400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.793800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.242630E-01 |
| Normal-vs-Age(61-80Yrs) |
2.22909999999521E-05 |
| Normal-vs-Age(81-100Yrs) |
1.284000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.342800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.365800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.579000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.896500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.020400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.139600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.796100E-04 |
| Normal-VS-Type2 PRCC |
4.970900E-04 |
| Normal-VS-KIRP CIMP |
9.990000E-01 |
| Normal-VS-Unclassified PRCC |
7.234600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.226000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.455230E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.136600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.646000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.533820E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.490200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.616600E-03 |
| Normal-vs-N1 |
3.584000E-01 |
| Normal-vs-N2 |
5.748800E-01 |
| N0-vs-N1 |
2.026800E-01 |
| N0-vs-N2 |
9.337600E-02 |
| N1-vs-N2 |
2.116400E-01 |
|
|
